Cydarm Technologies Scales Up For Expansion in the United States With Acceptance to iCyberCenter@bwtech in Baltimore

Vaughan Shanks, Founder and CEO, Cydarm

Melbourne-Headquartered Company Also Selected for Participation in Austrade Landing Pad Boot Camp in New York Highlighting RegTech for Financial Services

Cydarm Technologies, an Australian headquartered provider of case management solutions for cyber incident response, today announced that it will scale up its momentum in the United States cybersecurity market having been awarded entry into the internationally recognised 12-month iCyberCenter@bwtech global incubator program based within the University of Baltimore in Maryland.

The iCyberCenter@bwtech incubator program is designed to provide international cyber entrepreneurs with technical and business support as well as mentorship to facilitate entry into the U.S. cyber market.

By participating in the program, Cydarm will have the opportunity to participate in the iCyberCenter@bwtech CEO-level Executive Training Program which will provide direct help to the company to accelerate its understanding of the U.S. cyber market as well as provide support for developing effective U.S. market entry business strategies.  It also offers briefings, high-level industry connections and hands-on workshops delivered by leading subject matter experts as well as access to programs specifically designed for cybersecurity scale-ups.

“Attracting innovative international companies like Cydarm to the research and technology park at bwtech@UMBC fits well with our strategic focus and goals. We look forward to providing the programs and services to assist Cydarm with making a successful soft landing into Maryland!”  stated, Marjie Cota, Director Entrepreneurial Services, bwtech@UMBC.

In addition, Cydarm Technologies is also announcing its successful inclusion in an Austrade Landing Pad Boot Camp in New York for Australian RegTech companies ready to expand into the U.S. market. The program being held on 17th – 18th November will further support Cydarm’s expansion into the U.S. market by providing introductions to regulators, regulated entities in the financial services sector, advisors and investors in the New York region.

Dr. Vaughan Shanks, Founder and CEO, Cydarm, said, “We are excited to have been accepted into the iCyberCenter@bwtech incubator program and look forward to scalingour United States go-to-market strategy, while continuing our ongoing product development to solve the most pressing security challenges. Additionally, we are delighted to have the support of Austrade and look forward to participation in the upcoming RegTech Global Showcase in New York.”

During the program in New York, Cydarm will demonstrate its cybersecurity case management platform which enables cybersecurity operations teams to collaborate, integrate, respond and report with ease. This technology becomes particularly important as regulations specific to cyber incident response such as the Cyber Incident Reporting for Critical Infrastructure Act of 2022 (CIRCIA) bill in the U.S. and the Australian Security Legislation Amendment (Critical Infrastructure Protection) Act 2022 (SLACIP Act) have been passed.

Beyond its case management capabilities, Cydarm’s purpose-built attribute-based access control model and report builder enable information sharing of sensitive data to internal and external stakeholders, while closing the incident lifecycle feedback loop. This enables organisations to effectively utilise data specific to their own environment to inform decision making across strategy, planning, and budgeting.

Austrade NY’s Trade and Investment Commissioner, Steve Rank said “Australia is the world’s third largest RegTech hub, behind the U.S. and the UK, with over 10 percent of all RegTechs headquartered in Australia. Austrade is delighted to welcome Cydarm Technologies and another five leading Australian RegTech companies participating in Austrade’s New York Landing Pad program which includes an intensive boot camp to help accelerate their expansion into the U.S. market.”

For more information about Cydarm, visit